IBO vs IT · rev $18.0K vs P/E 16, rev $6.27B
Impact BioMedical, Inc. (IBO) versus Gartner Inc (IT) — a side-by-side from cached financials, not a winner call.
Impact BioMedical, Inc. (IBO) is a biotechnology company listed on US.
Gartner Inc (IT) is a information technology services company listed on US.
Latest reported IBO revenue for 2025-09-30 was $18.0K. Net income was -$1.5M. IBO currently screens at market cap $7.6M.
Latest reported IT revenue for 2024-12-31 was $6.27B. Net income was $1.25B. Revenue was up 6.1% from 2023-12-31 to 2024-12-31. IT currently screens at market cap $11.03B and trailing P/E 16.3.
IBO currently screens at market cap $7.6M. IT currently screens at market cap $11.03B and trailing P/E 16.3.
Not investment advice. Open the IBO and IT stock pages for the full models.
Not investment advice.